Jacob Thaysen
Vermögen: 7 Mio $ am 31.05.2026
Vermögen: 7 Mio $ am 31.05.2026
Jacob Thaysen is the founder of Cantion A. Dr. Thaysen is currently Chairman at Analytical Life Science & Diagnostics Association, Director, Chief Executive & Commercial Officer at Illumina, Inc. since 2023, Director at Lasergen, Inc., and Member of the American Cancer Society's CEOs Against Cancer.
Formerly, Dr. Thaysen was Director at Gen9, Inc., SVP & President-Life Sciences & Applied Markets at Agilent Technologies, Inc. from 2018 to 2023, Vice President-Research & Development at Cytologix Corp., and Vice President-System Development, R&D at Dako Denmark ApS from 2012 to 2013.
Education includes graduate and doctorate degrees from the Technical University of Denmark, conferred in 1998 and 2001 respectively.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ILLUMINA, INC. 0,03 % | 26.03.2026 | 40 313 ( 0,03 % ) | 7 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ILLUMINA, INC. | Vorstandsvorsitzender | 25.09.2023 |
Lasergen, Inc.
Lasergen, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures and markets measurement and monitoring instruments | Direktor/Vorstandsmitglied | - |
Analytical Life Science & Diagnostics Association | Vorsitzender | - |
American Cancer Society's CEOs Against Cancer | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | 05.09.2023 |
Cytologix Corp.
Cytologix Corp. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes automation technology for slide-based cellular diagnostics | Technik-/Wissenschafts-/F&E-Leiter | 18.05.2011 |
Cantion A/S
Cantion A/S Electronic Equipment/InstrumentsElectronic Technology Manufactures measuring and testing equipment | Gründer | - |
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Direktor/Vorstandsmitglied | - |
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Designs and manufactures cancer diagnostic systems | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Agilent Technologies, Inc.
Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
Illumina, Inc.
Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Health Technology |
Cytologix Corp.
Cytologix Corp. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes automation technology for slide-based cellular diagnostics | Commercial Services |
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Designs and manufactures cancer diagnostic systems | Health Technology |
Technical University of Denmark
Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cantion A/S
Cantion A/S Electronic Equipment/InstrumentsElectronic Technology Manufactures measuring and testing equipment | Electronic Technology |
Lasergen, Inc.
Lasergen, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures and markets measurement and monitoring instruments | Electronic Technology |
American Cancer Society's CEOs Against Cancer | |
Analytical Life Science & Diagnostics Association |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen